Chengliang Wang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Chengliang Wang has a total of 24 co-authors. Here are the top co-authors by number of shared publications:
- Chunxia Wang
Department of Pharmacy, Nanfang Hospital, Southern Medical University, Guangzhou 510515, China; Guangdong Provincial Key Laboratory of New Drug Screening, School of Pharmaceutical Sciences, Southern Medical University, Guangzhou 510515, China; Guangdong Provincial Key Laboratory of Chinese Medicine Pharmaceutics, School of Traditional Chinese Medicine, Southern Medical University, Guangzhou, Guangdong 510515, China
4 shared publications - Liying Ren
Department of Pharmacy, Nanfang Hospital, Southern Medical University, Guangzhou 510515, China
3 shared publications - Xiaoqian Huang
Department of Pharmacy, Nanfang Hospital, Southern Medical University, Guangzhou, 510515, China
2 shared publications - Yifan Yang
Endocrinology and Metabolism Group, Sydney Institute of Health Sciences/Sydney Institute of Traditional Chinese Medicine, Sydney, NSW, 2000, Australia
2 shared publications - Yuhao Li
The First Affiliated Hospital Guangzhou University of Chinese Medicine Guangzhou China
2 shared publications - Yuhao Li
Department of Pharmacy, Nanfang Hospital, Southern Medical University, Guangzhou, 510515, China; Endocrinology and Metabolism Group, Sydney Institute of Health Sciences/Sydney Institute of Traditional Chinese Medicine, Sydney, NSW, 2000, Australia
2 shared publications
Latest Publications
- 2 February 2026
- Published by Elsevier in Journal of Pharmaceutical and Biomedical Analysis
- Vol. 273, 117389
Development and validation of an UPLC–MS/MS method for simultaneous determination of meropenem and its open-ring metabolite in human serum and cerebrospinal fluid with application to clinical samples
- 2 February 2026
- Published by Elsevier in Journal of Pharmaceutical and Biomedical Analysis
- Vol. 273, 117389
Development and validation of an UPLC–MS/MS method for simultaneous determination of meropenem and its open-ring metabolite in human serum and cerebrospinal fluid with application to clinical samples
- 1 April 2021
- Published by Elsevier in Life Sciences
- Vol. 270, 119037
The protein kinase D1-mediated inflammatory pathway is involved in olanzapine-induced impairment of skeletal muscle insulin signaling in rats
- 1 April 2021
- Published by Elsevier in Life Sciences
- Vol. 270, 119037
The protein kinase D1-mediated inflammatory pathway is involved in olanzapine-induced impairment of skeletal muscle insulin signaling in rats